Terms: = Bone cancer AND CALR, ENSG00000179218, 811, P27797, SSA, RO, FLJ26680, cC1qR AND Treatment
144 results:
1. Observation of lymphadenopathy, systemic symptoms, and treatment in suspected indolent cutaneous B-cell lymphomas.
Puccio J; Huang Y; Viveiros MD; Reneau JC; Chung C; Spaccarelli N; Dulmage B
Arch Dermatol Res; 2024 May; 316(5):199. PubMed ID: 38775835
[TBL] [Abstract] [Full Text] [Related]
2. Multidisciplinary surgical considerations for en bloc resection of sacral chordoma: review of recent advances and a contemporary single-center series.
Schroeder C; de Lomba WC; Leary OP; De la Garza Ramos R; Gillette JS; Miner TJ; Woo AS; Fridley JS; Gokaslan ZL; Zadnik Sullivan PL
Neurosurg Focus; 2024 May; 56(5):E7. PubMed ID: 38691863
[TBL] [Abstract] [Full Text] [Related]
3. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.
GBD 2021 Diseases and Injuries Collaborators
Lancet; 2024 May; 403(10440):2133-2161. PubMed ID: 38642570
[TBL] [Abstract] [Full Text] [Related]
4. Probability of normal tissue complications for hematologic and gastrointestinal toxicity in postoperative whole pelvic radiotherapy for gynecologic malignancies using intensity-modulated proton therapy with robust optimization.
Yoshimura T; Yamada R; Kinoshita R; Matsuura T; Kanehira T; Tamura H; Nishioka K; Yasuda K; Taguchi H; Katoh N; Kobashi K; Hashimoto T; Aoyama H
J Radiat Res; 2024 May; 65(3):369-378. PubMed ID: 38499489
[TBL] [Abstract] [Full Text] [Related]
5. Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management.
Tefferi A; Vannucchi AM; Barbui T
Am J Hematol; 2024 Apr; 99(4):697-718. PubMed ID: 38269572
[TBL] [Abstract] [Full Text] [Related]
6. [Clinical characteristics and prognosis of patients with therapy-related myelodysplastic syndrome and acute myeloid leukemia arising from malignant tumors].
Xu XS; Ding H; Zhang X; Liao Y; Li H; Liu QY; Liu JZ; Zhang L; Huang J; Gong YP; Ma HB; Xiang B; Dai Y; Hou L; Shuai X; Niu T; Wu Y
Zhonghua Xue Ye Xue Za Zhi; 2023 Sep; 44(9):742-748. PubMed ID: 38049318
[No Abstract] [Full Text] [Related]
7. High cell-free DNA is associated with disease progression, inflammasome activation and elevated levels of inflammasome-related cytokine IL-18 in patients with myelofibrosis.
De Luca G; Lev PR; Camacho MF; Goette NP; Sackmann F; Castro Ríos MA; Moiraghi B; Cortes Guerrieri V; Bendek G; Carricondo E; Enrico A; Vallejo V; Varela A; Khoury M; Gutierrez M; Larripa IB; Marta RF; Glembotsky AC; Heller PG
Front Immunol; 2023; 14():1161832. PubMed ID: 38035089
[TBL] [Abstract] [Full Text] [Related]
8. A meta-analysis of the efficacy and safety of first-line chemotherapeutic agents for osteosarcoma.
Li Z; Ma X; Wang Z; Dong S; Wang B
Adv Clin Exp Med; 2024 May; 33(5):445-454. PubMed ID: 37747442
[TBL] [Abstract] [Full Text] [Related]
9. Quantitative uptake in 99m Tc-EDDA/HYNIC-TOC somatostatin receptor imaging - the effect of long-acting release somatostatin analogue therapy.
Gemmell AJ; Brown CM; Ray S; Small A
Nucl Med Commun; 2023 Nov; 44(11):944-952. PubMed ID: 37578312
[TBL] [Abstract] [Full Text] [Related]
10. The pharmacotherapeutic management of patients with myelofibrosis: looking beyond JAK inhibitors.
Duminuco A; Vetro C; Giallongo C; Palumbo GA
Expert Opin Pharmacother; 2023; 24(13):1449-1461. PubMed ID: 37341682
[TBL] [Abstract] [Full Text] [Related]
11. Impact of CDK4/6 Inhibitors on Aromatase Inhibitor-Associated Musculoskeletal Syndrome (AIMSS) in the Adjuvant Setting.
Skafida E; Andrikopoulou A; Terpos E; Markellos C; Moustafa S; Pectasides D; Dimopoulos MA; Zagouri F; Vassilopoulos D
Breast J; 2023; 2023():3614296. PubMed ID: 37293258
[TBL] [Abstract] [Full Text] [Related]
12. Comparing Risk for Second Primary cancers After Intensity-Modulated vs 3-Dimensional Conformal Radiation Therapy for Prostate cancer, 2002-2015.
Pithadia KJ; Advani PG; Citrin DE; Bekelman JE; Withrow DR; Berrington de Gonzalez A; Morton LM; Schonfeld SJ
JAMA Oncol; 2023 Aug; 9(8):1119-1123. PubMed ID: 37289449
[TBL] [Abstract] [Full Text] [Related]
13. MEAI: an artificial intelligence platform for predicting distant and lymph node metastases directly from primary breast cancer.
Fan J; Zhang L; Lv T; Liu Y; Sun H; Miao K; Jiang C; Li L; Pan X
J Cancer Res Clin Oncol; 2023 Sep; 149(11):9229-9241. PubMed ID: 37199837
[TBL] [Abstract] [Full Text] [Related]
14. Intensification of treatment with vinca alkaloid does not improve outcomes in pediatric patients with Langerhans cell histiocytosis: results from the JPLSG LCH-12 study.
Morimoto A; Shioda Y; Kudo K; Kanegane H; Imamura T; Koh K; Kosaka Y; Yuza Y; Nakazawa A; Saito AM; Watanabe T; Nakazawa Y
Int J Hematol; 2023 Jul; 118(1):107-118. PubMed ID: 36871086
[TBL] [Abstract] [Full Text] [Related]
15. Clinical and immunological features of patients with cancer-associated systemic sclerosis: An observational study.
Lopez L; Barnetche T; Galli G; Seneschal J; Blanchard E; Shipley E; Pellegrin JL; Lazaro E; Constans J; Duffau P; Schaeverbeke T; Richez C; Kostine M; Truchetet ME
Joint Bone Spine; 2023 May; 90(3):105555. PubMed ID: 36842760
[TBL] [Abstract] [Full Text] [Related]
16. Same-day adaptive palliative radiotherapy without prior CT simulation: Early outcomes in the FAST-METS study.
Nelissen KJ; Versteijne E; Senan S; Rijksen B; Admiraal M; Visser J; Barink S; de la Fuente AL; Hoffmans D; Slotman BJ; Verbakel WFAR
Radiother Oncol; 2023 May; 182():109538. PubMed ID: 36806603
[TBL] [Abstract] [Full Text] [Related]
17. The effect of long-acting somatostatin analogues on the uptake of [
Veerman CHAM; Siebinga H; de Vries-Huizing DMV; Tesselaar MET; Hendrikx JJMA; Stokkel MPM; Aalbersberg EA
Eur J Nucl Med Mol Imaging; 2023 Apr; 50(5):1434-1441. PubMed ID: 36598536
[TBL] [Abstract] [Full Text] [Related]
18. A Retrospective Chart Review of 809 Patients with Physician-Diagnosed Essential Thrombocythemia Receiving Cytoreductive Therapy in US Community Oncology Practices.
Yu J; Paranagama D; Hanna B; Tang J; Chojecki A
Acta Haematol; 2023; 146(1):26-36. PubMed ID: 36001945
[TBL] [Abstract] [Full Text] [Related]
19. Impact of molecular profiling on the management of patients with myelofibrosis.
Pastor-Galán I; Martín I; Ferrer B; Hernández-Boluda JC
Cancer Treat Rev; 2022 Sep; 109():102435. PubMed ID: 35839532
[TBL] [Abstract] [Full Text] [Related]
20. How I Diagnose Primary Myelofibrosis.
Prakash S; Orazi A
Am J Clin Pathol; 2022 Apr; 157(4):518-530. PubMed ID: 35238345
[TBL] [Abstract] [Full Text] [Related]
[Next]
